Growth Differentiation Factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kahli, Abdelkader ^a,b   Guenancia, Charles ^a,b   Zeller, Marianne ^a   Grosjean, Sandrine ^a,b   Stamboul, Karim ^a,b   Rochette, Luc ^a   Girard, Claude ^a,b   Vergely, Catherine ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN LIKE 1 PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; HEMOGLOBIN; HORMONE RELEASE INHIBITING FACTOR; HYDROPEROXIDE; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OVARY PEPTIDE HORMONE; TROPONIN I; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; ANTIOXIDANT; BIOLOGICAL MARKER; FOLLISTATIN RELATED PROTEIN; FSTL1 PROTEIN, HUMAN; HYDROGEN PEROXIDE; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PEROXIDASE;

ACUTE KIDNEY FAILURE; AGED; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEART INJURY; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; KIDNEY INJURY; MALE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; HEART DISEASES; METABOLISM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROCEDURES;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; FOLLISTATIN-RELATED PROTEINS; GROWTH DIFFERENTIATION FACTOR 15; HEART DISEASES; HUMANS; HYDROGEN PEROXIDE; INTENSIVE CARE UNITS; LIPOCALINS; MALE; MIDDLE AGED; PEROXIDASE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; TROPONIN I;

EID: 84923335195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105759     Document Type: Article

References (38)

1. Wildhirt SM, Schulze C, Schulz C, Egi K, Brenner P, et al. (2001) Reduction of systemic and cardiac adhesion molecule expression after off-pump versus conventional coronary artery bypass grafting. Shock 16 Suppl 1: 55-59.
2. Goudeau JJ, Clermont G, Guillery O, Lemaire-Ewing S, Musat A, et al. (2007) In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J Cardiovasc Pharmacol 49: 39-45. (Pubitemid 46184330)
3. Clermont G, Vergely C, Jazayeri S, Lahet JJ, Goudeau JJ, et al. (2002) Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 96: 80-87. (Pubitemid 34032486)
4. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
5. Ago T, Sadoshima J (2006) GDF15, a cardioprotective TGF-beta superfamily protein. Circ Res 98: 294-297.
6. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, et al. (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 98: 351-360.
7. Wollert KC, Kempf T, Peter T, Olofsson S, James S, et al. (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115: 962-971. (Pubitemid 46328289)
8. Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, et al. (2009) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 30: 1057-1065.
9. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, et al. (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50: 1054-1060. (Pubitemid 47348231)
10. Hochholzer W, Morrow DA, Giugliano RP (2010) Novel biomarkers in cardiovascular disease: update 2010. Am Heart J 160: 583-594.
11. Widera C, Giannitsis E, Kempf T, Korf-Klingebiel M, Fiedler B, et al. (2012) Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome. Clin Chem 58: 1233-1241.
12. Heringlake M, Charitos EI, Gatz N, Kabler JH, Beilharz A, et al. (2013) Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients. J Am Coll Cardiol 61: 672-681.
13. Breit SN, Carrero JJ, Tsai VW, Yagoutifam N, Luo W, et al. (2012) Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant 27: 70-75.
14. Ho JE, Hwang SJ, Wollert KC, Larson MG, Cheng S, et al. (2013) Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem 59: 1613-1620.
15. Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T, et al. (2007) Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 53: 284-291. (Pubitemid 46338273)
16. Doise JM, Aho LS, Quenot JP, Guilland JC, Zeller M, et al. (2008) Plasma antioxidant status in septic critically ill patients: a decrease over time. Fundam Clin Pharmacol 22: 203-209. (Pubitemid 351392956)
17. Lorgis L, Zeller M, Dentan G, Sicard P, Richard C, et al. (2010) The free oxygen radicals test (FORT) to assess circulating oxidative stress in patients with acute myocardial infarction. Atherosclerosis 213: 616-621.
18. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543. (Pubitemid 37169339)
19. Wagener G, Jan M, Kim M, Mori K, Barasch JM, et al. (2006) Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105: 485-491. (Pubitemid 44310430)
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470. (Pubitemid 29135798)
21. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, et al. (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31.
22. Ho JE, Mahajan A, Chen MH, Larson MG, McCabe EL, et al. (2012) Clinical and genetic correlates of growth differentiation factor 15 in the community. Clin Chem 58: 1582-1591.
23. Eggers KM, Kempf T, Wallentin L, Wollert KC, Lind L (2013) Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals. Clin Chem 59: 1091-1098.
24. Kempf T, Guba-Quint A, Torgerson J, Magnone MC, Haefliger C, et al. (2012) Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol 167: 671-678.
25. Rohatgi A, Patel P, Das SR, Ayers CR, Khera A, et al. (2012) Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study. Clin Chem 58: 172-182.
26. Kempf T, Bjorklund E, Olofsson S, Lindahl B, Allhoff T, et al. (2007) Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 28: 2858-2865. (Pubitemid 350233034)
27. Foley PW, Stegemann B, Ng K, Ramachandran S, Proudler A, et al. (2009) Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur Heart J 30: 2749-2757.
28. Zhang M, Lu S, Wu X, Chen Y, Song X, et al. (2012) Multimarker approach for the prediction of cardiovascular events in patients with mild to moderate coronary artery lesions. A 3-year follow-up study. Int Heart J 53: 85-90.
29. Wollert KC (2007) Growth-differentiation factor-15 in cardiovascular disease: from bench to bedside, and back. Basic Res Cardiol 102: 412-415.
30. Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, et al. (2007) Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 116: 1540-1548. (Pubitemid 47511417)
31. Xu X, Li Z, Gao W (2011) Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers 16: 466-475.
32. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, et al. (2009) The inflammatory response to cardiopulmonary bypass: part 1-mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 23: 223-231.
33. Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, et al. (2008) Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 117: 3099-3108.
34. Widera C, Horn-Wichmann R, Kempf T, Bethmann K, Fiedler B, et al. (2009) Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. Clin Chem 55: 1794-1800.
35. van der Veen BS, de Winther MP, Heeringa P (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11: 2899-2937.
36. Simonson MS, Tiktin M, Debanne SM, Rahman M, Berger B, et al. (2012) The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study. Am J Physiol Renal Physiol 302: F820-829.
37. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, et al. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13: 1096-1101. (Pubitemid 47517510)
38. Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, et al. (2010) Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol 148: 449-455.